Assessing the Risks of Adverse Endocrine-Mediated Effects: Where to from Here?
- 31 August 1997
- journal article
- review article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 26 (1) , 80-93
- https://doi.org/10.1006/rtph.1997.1124
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A hierarchical approach to the evaluation of chemicals for estrogenic and other endocrine-disrupting propertiesEnvironmental Toxicology and Pharmacology, 1997
- Activity of Raloxifene in Immature and Ovariectomized Rat Uterotrophic AssaysRegulatory Toxicology and Pharmacology, 1997
- The challenge posed by endocrine-disrupting chemicals.Environmental Health Perspectives, 1997
- Synergy between synthetic oestrogens?Nature, 1997
- Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.Endocrinology, 1996
- Mad cows, bats and baby milkNature, 1996
- Synergistic Activation of Estrogen Receptor with Combinations of Environmental ChemicalsScience, 1996
- Exposure of environmental estrogenic compound nonlyphenol to noble rats alters cell-cycle kinetics in the mammary glandEndocrine, 1996
- Developmental effects of endocrine-disrupting chemicals in wildlife and humans.Environmental Health Perspectives, 1993
- Too Many Rodent Carcinogens: Mitogenesis Increases MutagenesisScience, 1990